Zymeworks Announces New Director Nominee
“With this in mind, we are delighted to invite Dr. Davidson to join our board of directors.
- “With this in mind, we are delighted to invite Dr. Davidson to join our board of directors.
- Her lab studies have paved the way for new clinical trials of drugs that exploit these pathways to kill breast cancer.
- Prior to joining FHCC, she spent time at the National Cancer Institute, Johns Hopkins in Baltimore and the University of Pittsburgh.
- Dr. Davidson completed her residency in Internal Medicine at John Hopkins Hospital and a fellowship at the National Cancer Institute.